WallStreetZenWallStreetZen

NASDAQ: CARM
Carisma Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CARM

Based on 2 analysts offering 12 month price targets for Carisma Therapeutics Inc.
Min Forecast
$6.00+252.94%
Avg Forecast
$7.50+341.18%
Max Forecast
$9.00+429.41%

Should I buy or sell CARM stock?

Based on 2 analysts offering ratings for Carisma Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CARM stock forecasts and price targets.

CARM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-11
lockedlocked$00.00+00.00%2024-04-02

1 of 1

Forecast return on equity

Is CARM forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.5%

Forecast return on assets

Is CARM forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CARM revenue forecast

What is CARM's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$15.8M+6.13%
Avg 2 year Forecast
$26.0M+74.27%
Avg 3 year Forecast
$68.0M+355.79%
CARM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CARM revenue growth forecast

How is CARM forecast to perform vs Biotechnology companies and vs the US market?
Company
57.65%
Industry
37.57%
Market
10.16%
CARM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CARM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CARM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CARM$1.70$7.50+341.18%Strong Buy
TSBX$3.06N/AN/A
ANTX$2.37$6.50+174.26%Buy
DTIL$10.23$60.00+486.51%Buy
ANEB$2.71N/AN/A
View Top Biotech Stocks

Carisma Therapeutics Stock Forecast FAQ

Is Carisma Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CARM) stock is to Strong Buy CARM stock.

Out of 2 analysts, 1 (50%) are recommending CARM as a Strong Buy, 1 (50%) are recommending CARM as a Buy, 0 (0%) are recommending CARM as a Hold, 0 (0%) are recommending CARM as a Sell, and 0 (0%) are recommending CARM as a Strong Sell.

If you're new to stock investing, here's how to buy Carisma Therapeutics stock.

What is CARM's revenue growth forecast for 2024-2026?

(NASDAQ: CARM) Carisma Therapeutics's forecast annual revenue growth rate of 57.65% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Carisma Therapeutics's revenue in 2024 is $14,919,000.On average, 3 Wall Street analysts forecast CARM's revenue for 2024 to be $657,742,941, with the lowest CARM revenue forecast at $643,909,277, and the highest CARM revenue forecast at $664,680,544. On average, 2 Wall Street analysts forecast CARM's revenue for 2025 to be $1,080,105,884, with the lowest CARM revenue forecast at $664,680,544, and the highest CARM revenue forecast at $1,495,531,224.

In 2026, CARM is forecast to generate $2,824,892,312 in revenue, with the lowest revenue forecast at $2,824,892,312 and the highest revenue forecast at $2,824,892,312.

What is CARM's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CARM) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CARM's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CARM price target, the average CARM price target is $7.50, with the highest CARM stock price forecast at $9.00 and the lowest CARM stock price forecast at $6.00.

On average, Wall Street analysts predict that Carisma Therapeutics's share price could reach $7.50 by Apr 11, 2025. The average Carisma Therapeutics stock price prediction forecasts a potential upside of 341.18% from the current CARM share price of $1.70.

What is CARM's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CARM) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.